Logo image of HTFL

HEARTFLOW INC (HTFL) Stock Fundamental Analysis

USA - NASDAQ:HTFL - US42238D1072 - Common Stock

33.77 USD
+0.3 (+0.9%)
Last: 10/17/2025, 5:22:59 PM
34.19 USD
+0.42 (+1.24%)
After Hours: 10/17/2025, 5:22:59 PM
Fundamental Rating

2

HTFL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. HTFL may be in some trouble as it scores bad on both profitability and health. HTFL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HTFL had negative earnings in the past year.
HTFL Yearly Net Income VS EBIT VS OCF VS FCFHTFL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

HTFL's Return On Assets of -60.51% is on the low side compared to the rest of the industry. HTFL is outperformed by 82.86% of its industry peers.
Industry RankSector Rank
ROA -60.51%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HTFL Yearly ROA, ROE, ROICHTFL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 500 1K

1.3 Margins

HTFL has a Gross Margin of 75.07%. This is in the better half of the industry: HTFL outperforms 80.00% of its industry peers.
The Profit Margin and Operating Margin are not available for HTFL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HTFL Yearly Profit, Operating, Gross MarginsHTFL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

HTFL does not have a ROIC to compare to the WACC, probably because it is not profitable.
HTFL has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, HTFL has a worse debt to assets ratio.
HTFL Yearly Shares OutstandingHTFL Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M 80M
HTFL Yearly Total Debt VS Total AssetsHTFL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -2.86, we must say that HTFL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of HTFL (-2.86) is worse than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.86
ROIC/WACCN/A
WACC10.32%
HTFL Yearly LT Debt VS Equity VS FCFHTFL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 50M -50M 100M

2.3 Liquidity

A Current Ratio of 3.60 indicates that HTFL has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.60, HTFL is doing good in the industry, outperforming 80.00% of the companies in the same industry.
HTFL has a Quick Ratio of 3.60. This indicates that HTFL is financially healthy and has no problem in meeting its short term obligations.
HTFL's Quick ratio of 3.60 is fine compared to the rest of the industry. HTFL outperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.6
Quick Ratio 3.6
HTFL Yearly Current Assets VS Current LiabilitesHTFL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 50M 100M

More info and screens

4

3. Growth

3.1 Past

HTFL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.04%, which is quite impressive.
HTFL shows a strong growth in Revenue. In the last year, the Revenue has grown by 44.32%.
EPS 1Y (TTM)22.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)44.32%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

HTFL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.73% yearly.
HTFL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.68% yearly.
EPS Next Y-5.53%
EPS Next 2Y21.82%
EPS Next 3Y18.73%
EPS Next 5YN/A
Revenue Next Year34.51%
Revenue Next 2Y29.45%
Revenue Next 3Y27.68%
Revenue Next 5YN/A

3.3 Evolution

HTFL Yearly Revenue VS EstimatesHTFL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
HTFL Yearly EPS VS EstimatesHTFL Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

HTFL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HTFL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HTFL Price Earnings VS Forward Price EarningsHTFL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HTFL Per share dataHTFL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as HTFL's earnings are expected to grow with 18.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.82%
EPS Next 3Y18.73%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HTFL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEARTFLOW INC

NASDAQ:HTFL (10/17/2025, 5:22:59 PM)

After market: 34.19 +0.42 (+1.24%)

33.77

+0.3 (+0.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)09-19 2025-09-19/bmo
Earnings (Next)N/A N/A
Inst Owners27.97%
Inst Owner ChangeN/A
Ins Owners20.87%
Ins Owner Change41.78%
Market Cap2.82B
Analysts82
Price Target37.49 (11.02%)
Short Float %0.91%
Short Ratio1.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 22.39
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.2
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.51
BVpS-1.51
TBVpS-1.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -60.51%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.07%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.6
Quick Ratio 3.6
Altman-Z -2.86
F-ScoreN/A
WACC10.32%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-5.53%
EPS Next 2Y21.82%
EPS Next 3Y18.73%
EPS Next 5YN/A
Revenue 1Y (TTM)44.32%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year34.51%
Revenue Next 2Y29.45%
Revenue Next 3Y27.68%
Revenue Next 5YN/A
EBIT growth 1Y16.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year11.7%
EBIT Next 3Y15.76%
EBIT Next 5YN/A
FCF growth 1Y11.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.72%
OCF growth 3YN/A
OCF growth 5YN/A